Civil Services Examination · Question 122
Hybridoma technology is a new biotechnological approach for commercial production of
Show answer & explanationShow explanation
Answer: (A) monoclonal antibodies
Concept: Invented in 1975 by Georges Köhler and César Milstein, hybridoma technology fuses a specific antibody-producing B-lymphocyte with an immortal myeloma (bone marrow cancer) cell using polyethylene glycol (PEG). Product: The resulting hybrid cell ('hybridoma') combines immortality with single-epitope specificity, enabling large-scale commercial production of identical 'monoclonal antibodies' (mAbs). Result: Hybridoma technology is used for the commercial production of monoclonal antibodies. Related Facts: • Applications of Monoclonal Antibodies: Pregnancy test kits (detecting hCG), targeted cancer immunotherapy (e.g., Rituximab, Trastuzumab), diagnostic ELISA tests, and preventing organ-transplant rejection. • Nobel Prize (1984): Awarded to Niels Jerne, Georges Köhler, and César Milstein for the discovery of the principle for production of monoclonal antibodies. Correct Answer: (a) monoclonal antibodies
